| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |